Search

everythinglearnresearchcommunity

for

Search:↓

Cylindromas likely originate from hair follicle stem cells, not sweat glands.

A rare skin condition in a boy is likely due to a specific genetic mutation pattern.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Early intervention is important for limited systemic sclerosis patients due to higher pain and ulceration risks.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

A 54-year-old man with painful skin blisters and fever was diagnosed with Sweet syndrome and successfully treated with corticosteroids.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Chronic cutaneous lupus erythematosus should be considered when acne treatments don't work.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

The patient has Chronic Cutaneous Lupus, a skin condition causing plaques and hair loss.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Skin rashes can help diagnose COVID-19 early.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.